China’s National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related...
GlaxoSmithKline Plc (GSK, NYSE: GSK) announced positive Phase II clinical data for its mRNA seasonal...
The National Medical Products Administration (NMPA) issued the Announcement on Further Strengthening the Management of...
Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, announced that its SKINVIVE by Juvéderm, an injectable...
Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of Beijing Centergate Technologies (SHE: 000931), has received...
Novartis (NYSE: NVS) announced positive topline results from its Phase III REMODEL-1/-2 clinical trials of...
CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765) announced that SYS6010, its epidermal growth factor receptor...
Huadong Medicine (SHE: 000963) announced that it signed a new additional collaboration agreement with its...
Sino Biopharmaceutical (HKG: 1177) announced that its subsidiary, Chia Tai Tianqing (CTTQ), entered into an...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its novel bispecific...
Simcere Zaiming Pharmaceutical, an oncology-focused innovative drug company under Simcere Pharmaceutical (HKG: 2096), announced that...
The Center for Drug Evaluation (CDE) of China‘s National Medical Products Administration (NMPA) issued the...
China’s Shanghai RAAS (SHE: 002252) announced that its candidate SR604 has been included by the...
Eisai Co., Ltd. (TYO: 4523) announced that LEQEMBI IQLIK, a subcutaneous auto-injector formulation of lecanemab,...
President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices...
Laekna Therapeutics Shanghai Co., Ltd. (HKG: 2105) announced that it has initiated a Phase I...
Johnson & Johnson MedTech and Jiangsu CED Medical Technology Co., Ltd. (“CED Medical”) have signed...
CSPC Pharmaceutical Group (HKG: 1093) announced that the Phase I clinical trial of SYH2092, an...
Ocumension Therapeutics (HKG: 1477) announced that OT-202, the company’s first-in-class candidate for the treatment of...
Eli Lilly (NYSE: LLY) and Merida Biosciences, a biotechnology company advancing a new class of...